107 related articles for article (PubMed ID: 7471607)
21. Hemodialysis of theophylline in uremic patients.
Lee CS; Marbury TC; Perrin JH; Fuller TJ
J Clin Pharmacol; 1979 Apr; 19(4):219-26. PubMed ID: 438357
[TBL] [Abstract][Full Text] [Related]
22. Determination of vancomycin and gentamicin clearance in an in vitro, closed loop dialysis system.
Jang SM; Cardone KE; Nolin TD; Mason DL; Grabe DW
BMC Nephrol; 2014 Dec; 15():204. PubMed ID: 25526750
[TBL] [Abstract][Full Text] [Related]
23. Hemodialysis of phenytoin in a uremic patient.
Adler DS; Martin E; Gambertoglio JG; Tozer TN; Spire JP
Clin Pharmacol Ther; 1975 Jul; 18(1):65-9. PubMed ID: 1149364
[TBL] [Abstract][Full Text] [Related]
24. Relationship between effective ionic dialysance and in vivo urea clearance during hemodialysis.
Lindsay RM; Bene B; Goux N; Heidenheim AP; Landgren C; Sternby J
Am J Kidney Dis; 2001 Sep; 38(3):565-74. PubMed ID: 11532690
[TBL] [Abstract][Full Text] [Related]
25. Extracorporeal clearance of colistin methanesulphonate and formed colistin in end-stage renal disease patients receiving intermittent haemodialysis: implications for dosing.
Jitmuang A; Nation RL; Koomanachai P; Chen G; Lee HJ; Wasuwattakul S; Sritippayawan S; Li J; Thamlikitkul V; Landersdorfer CB
J Antimicrob Chemother; 2015; 70(6):1804-11. PubMed ID: 25698772
[TBL] [Abstract][Full Text] [Related]
26. Elimination of intravenous alendronate by hemodialysis: A kinetic study.
Iseri K; Watanabe M; Lee XP; Yamada M; Ryu K; Iyoda M; Uchida N; Sato K; Shibata T
Hemodial Int; 2019 Oct; 23(4):466-471. PubMed ID: 31328884
[TBL] [Abstract][Full Text] [Related]
27. Hemodialysis removal of norfloxacin.
Lau AH; Tang I; Fitzloff J; Jain R
Chemotherapy; 1994; 40(6):369-73. PubMed ID: 7842819
[TBL] [Abstract][Full Text] [Related]
28. Absorption and disposition of ibuprofen in hemodialyzed uremic patients.
Senekjian HO; Lee CS; Kuo TH; Au DS; Krothapalli R
Eur J Rheumatol Inflamm; 1983; 6(2):155-62. PubMed ID: 6673979
[TBL] [Abstract][Full Text] [Related]
29. Hemodialyzability of sertraline.
Schwenk MH; Verga MA; Wagner JD
Clin Nephrol; 1995 Aug; 44(2):121-4. PubMed ID: 8529300
[TBL] [Abstract][Full Text] [Related]
30. Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency.
Haubitz M; Bohnenstengel F; Brunkhorst R; Schwab M; Hofmann U; Busse D
Kidney Int; 2002 Apr; 61(4):1495-501. PubMed ID: 11918757
[TBL] [Abstract][Full Text] [Related]
31. The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes.
Etinger A; Kumar SR; Ackley W; Soiefer L; Chun J; Singh P; Grossman E; Matalon A; Holzman RS; Meijers B; Lowenstein J
PLoS One; 2018; 13(2):e0192770. PubMed ID: 29470534
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of cyclophosphamide in man.
Cohen JL; Jao JY; Jusko WJ
Br J Pharmacol; 1971 Nov; 43(3):677-80. PubMed ID: 5157730
[TBL] [Abstract][Full Text] [Related]
33. Increasing dialysate flow rate increases dialyzer urea clearance and dialysis efficiency: an in vivo study.
Azar AT
Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):1023-9. PubMed ID: 19861865
[TBL] [Abstract][Full Text] [Related]
34. The effect of hemodialysis on piperacillin pharmacokinetics.
Heim-Duthoy KL; Halstenson CE; Abraham PA; Matzke GR
Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):680-4. PubMed ID: 3818147
[TBL] [Abstract][Full Text] [Related]
35. [Pharmacokinetics and clearance of ciprofloxacin and amikacin in continuous hemodialysis].
Cotera A; Aguila R; Gaete L; Saffie A; Lorca E; Thambo S
Rev Med Chil; 1995 Jun; 123(6):742-8. PubMed ID: 8525228
[TBL] [Abstract][Full Text] [Related]
36. Enhanced clearance of highly protein-bound drugs by albumin-supplemented dialysate during modeled continuous hemodialysis.
Churchwell MD; Pasko DA; Smoyer WE; Mueller BA
Nephrol Dial Transplant; 2009 Jan; 24(1):231-8. PubMed ID: 18723569
[TBL] [Abstract][Full Text] [Related]
37. Nonlinear plasma protein binding and haemodialysis clearance of prednisolone.
Frey FJ; Gambertoglio JG; Frey BM; Benet LZ; Amend WJ
Eur J Clin Pharmacol; 1982; 23(1):65-74. PubMed ID: 6751835
[TBL] [Abstract][Full Text] [Related]
38. Elimination of iohexol, a low osmolar nonionic contrast medium, by hemodialysis in patients with chronic renal failure.
Waaler A; Svaland M; Fauchald P; Jakobsen JA; Kolmannskog F; Berg KJ
Nephron; 1990; 56(1):81-5. PubMed ID: 2234253
[TBL] [Abstract][Full Text] [Related]
39. Validation of urinary excretion of cyclophosphamide as a biomarker of exposure by studying its renal clearance at high and low plasma concentrations in cancer patients.
Hedmer M; Höglund P; Cavallin-Ståhl E; Albin M; Jönsson BA
Int Arch Occup Environ Health; 2008 Jan; 81(3):285-93. PubMed ID: 17579883
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole during hemodialysis.
Nissenson AR; Wilson C; Holazo A
Am J Nephrol; 1987; 7(4):270-4. PubMed ID: 3500644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
